CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Mar. 31, 2022			117,863,000
Beginning balance at Mar. 31, 2022	$ 182,366	$ (46,160)	$ 118	$ 956,599	$ (92,832)	$ (7,913)	$ (766,438)	$ 46,672
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, less withholding (in shares)			1,796,000
Issuance of common stock under stock plans, less withholding	65		$ 2	63
Stock-based compensation expense	31,807			31,807
Unrealized investment loss	(94)					(94)
Foreign currency translation adjustment	(8,419)			(35)		(8,384)
Net loss	(26,043)						(26,043)
Ending balance (in shares) at Jun. 30, 2022			119,659,000
Ending balance at Jun. 30, 2022	$ 133,522		$ 120	895,602		(16,391)	(745,809)
Beginning balance (in shares) at Mar. 31, 2023	114,659,255		114,659,000
Beginning balance at Mar. 31, 2023	$ 99,906		$ 115	905,635		(12,927)	(792,917)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, less withholding (in shares)			3,535,000
Issuance of common stock under stock plans, less withholding	0		$ 3	(3)
Stock-based compensation expense	18,559			18,559
Issuance of common stock under stock plans, less withholding, related to Fuze acquisition	0		$ 1	(1)
Stock-based compensation expense related to Fuze acquisition (in shares)			1,038,000
Unrealized investment loss	290					290
Foreign currency translation adjustment	1,441					1,441
Net loss	$ (15,327)						(15,327)
Ending balance (in shares) at Jun. 30, 2023	119,231,643		119,232,000
Ending balance at Jun. 30, 2023	$ 104,869		$ 119	$ 924,190		$ (11,196)	$ (808,244)